Mettler-Toledo International, Inc. $MTD Stock Holdings Raised by Wealth Enhancement Advisory Services LLC

Key Points

• Wealth Enhancement Advisory Services LLC raised its stake in Mettler-Toledo International, Inc. by 13.1% in Q2, owning a total of 2,490 shares valued at approximately $3.01 million.
• Recent insider trading saw CFO Shawn Vadala sell 300 shares of stock for about $397,500, reflecting a 5.56% decrease in his position.
• The consensus rating for Mettler-Toledo International is a "Moderate Buy", with price targets ranging from $1,275 to $1,600, according to several analysts.

Wealth Enhancement Advisory Services LLC raised its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 13.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 2,490 shares of the medical instruments supplier's stock after purchasing an additional 288 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Mettler-Toledo International were worth $3,011,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Greenleaf Trust grew its position in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock valued at $1,030,000 after buying an additional 10 shares during the last quarter. Brooklyn Investment Group grew its position in shares of Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock valued at $104,000 after buying an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock valued at $740,000 after buying an additional 11 shares during the last quarter. Albion Financial Group UT grew its position in shares of Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock valued at $890,000 after buying an additional 11 shares during the last quarter. Finally, TD Private Client Wealth LLC grew its position in shares of Mettler-Toledo International by 5.4% during the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after buying an additional 11 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares of the company's stock, valued at approximately $6,750,875. This represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 1.94% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Barclays assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective for the company. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Citigroup upped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research report on Thursday, August 21st. Bank of America upped their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a research report on Monday, September 22nd. Finally, Evercore ISI decreased their target price on shares of Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $1,325.56.

Mettler-Toledo International Trading Down 0.6%

Shares of NYSE:MTD opened at $1,202.72 on Friday. The company has a 50 day moving average of $1,269.22 and a 200-day moving average of $1,184.98. The firm has a market cap of $24.77 billion, a P/E ratio of 30.46, a P/E/G ratio of 3.63 and a beta of 1.37. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the business posted $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.